top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

AbbVie Acquires Aliada Therapeutics for $1.4B to Expand Alzheimer's Research Portfolio

North Chicago, IL, October 28, 2024 (Reuters) -- AbbVie will acquire Aliada Therapeutics for $1.4 billion to gain access to an early-stage Alzheimer's therapy. This acquisition reflects AbbVie's dedication to strengthening its neuroscience portfolio.  The competitive acquisition process underscores industry interest in innovative Alzheimer's treatments.


Read full article here.

Recent Posts

See All

コメント


Life Science Headlines
bottom of page